Financial News

<< Back
ViewRay to Present at the 39th Annual J.P. Morgan Healthcare Conference

CLEVELAND, January 11, 2021 — ViewRay, Inc. (NASDAQ: VRAY) today announced its participation in the 39th Annual J.P. Morgan Healthcare Conference. Scott Drake, President and CEO, is scheduled to present at 10:00 a.m. Eastern Time on Thursday, January 14, 2021.

An audio webcast of the Company’s presentation will be available on the “Financial Events and Webinars” portion of ViewRay’s investor website at A replay of the webcast will be available for 14 days after the date of the presentation.

About ViewRay

ViewRay, Inc. (Nasdaq: VRAY), designs, manufactures, and markets the MRIdian® radiation therapy system. MRIdian is built upon a proprietary high-definition MR imaging system designed from the ground up to address the unique challenges and clinical workflow for advanced radiation oncology. Unlike MR systems used in diagnostic radiology, MRIdian's high-definition MR was purpose built to address specific challenges, including beam distortion, skin toxicity, and other concerns that potentially may arise when high magnetic fields interact with radiation beams. ViewRay and MRIdian are registered trademarks of ViewRay, Inc.


Investor Relations:
Michaella Gallina
VP, Chief of Staff, Head of Investor Relations and Communications
ViewRay, Inc.
1-844-MRIdian (674-3426)

Media Enquiries:
Karen Hackstaff
Vice President, Strategy and Branding
ViewRay, Inc.
Phone: +1 408-242-2994

# # #

Stock Quote

Data Provided by Refinitiv. Minimum 15 minutes delayed.

E-mail Alerts

Alerts are e-mailed to you whenever certain new company information is posted to this site. Sign-up Now!
Click here for E-mail Alerts

Transfer Agent
American Stock Transfer & Trust Company, LLC
6201 15th Avenue
Brooklyn, NY 11219
(800) 937-5449

In Need of Customer Support? Contact

  Language Select